PSPC1

Paraspeckle component 1 · Q8WXF1 · PSPC1 on Sugi Atlas →

0 patent compounds predicted against PSPC1, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to PSPC1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Efficacy and Safety Assessment of Oral LBH589 in Adult Patients With Advanced Soft TIssue Sarcoma After Pre-treatment Failure PHASE2COMPLETED
Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery PHASE1/PHASE2ACTIVE_NOT_RECRUITING
A Phase 1/2 Trial SRA737 in Combination With Gemcitabine and Cisplatin or Gemcitabine Alone in Advanced Cancer Subjects PHASE1/PHASE2COMPLETED
PS-341 and Radiation to Treat Advanced Cancer of the Head and Neck PHASE1COMPLETED
Immunophenotyping and Xist Gene in AML nanUNKNOWN
Biocollection in MyeloDysplastic Syndrome (P-MDS) nanRECRUITING
Mesenchymal Stem Cells in NPM1 Mutated Low Risk Acute Myeloid Leukemia: a Study of the Tumor Microenvironment and Its Contribution to the Outcome nanCOMPLETED
Association of SNPs in Long Intergenic Noncoding RNA 00511 (LINC00511) With Breast Cancer Among the Egyptian Population nanCOMPLETED
LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis nanCOMPLETED
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
Assessment Of Long Noncoding RNA CCAT1 In Colorectal Cancer Patients nanUNKNOWN
SRSF2 Gene Mutation in Patients With t-MDS/AML nanCOMPLETED
Diagnosis of RSTS: Identification of the Acetylation Profiles as Epigenetic Markers for Assessing Causality of CREBBP and EP300 Variants. nanUNKNOWN
Risk of HCC in Cirrhotic Patients Post DAAs Ttt nanUNKNOWN
Risk Factors for Progressive Supranuclear Palsy (PSP) nanCOMPLETED
Circulating Markers for Ischemic Heart Disease nanRECRUITING
Studying The Role of Key Epigenetic Mediators in Breast Cancer Patients nanRECRUITING
Circadian Rhythms and Sleep in Familial DSPS and ASPS nanCOMPLETED
Whole-genome Sequencing Study in Patients With Diminished Ovarian Reserve nanUNKNOWN
Diagnosis of Inflammatory Bowel Disease nanNOT_YET_RECRUITING
RNA Sequencing in the Framingham Heart Study Third Generation Cohort Exam 2 nanCOMPLETED
The Difference of microRNA and Circulating Tumor Cells in Blood Among Cancer Patients With Immunotherapy nanRECRUITING
Progression Follow up of the First-degree Relatives of Patients With REM Sleep Behavior Disorder nanUNKNOWN
Biological Aging Hallmarks-Guided Integrative TCM and Conventional Medicine in Post-Treatment Unexplained Female Infertility nanRECRUITING
Hippotherapy in Children With Spinal Muscular Atrophy nanRECRUITING
Study of the Effect of Innate on the Inflammatory Response to Endotoxin nanRECRUITING
Molecular Disease Profile of Hematological Malignancies nanUNKNOWN
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
MicroRNA-1 (miRNA-1) and MicroRNA-133a (miRNA-133a) Levels After Acute Exercise in Ultimate Frisbee Athletes nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a PSPC1 binder may also engage these)

ProteinNameSimilarity
Q4KLH4 1.000 Q4KLH4 →
Q1LZD9 1.000 Q1LZD9 →
Q8R326 1.000 Q8R326 →
Q5ZK88 1.000 Q5ZK88 →
Q1JPY8 1.000 Q1JPY8 →
Q5RFL9 1.000 Q5RFL9 →
NONO Non-POU domain-containing octamer-binding protein 0.998 landscape →
Q5FVM4 0.996 Q5FVM4 →
Q99K48 0.996 Q99K48 →
Q8VIJ6 0.992 Q8VIJ6 →
SFPQ Splicing factor, proline- and glutamine-rich 0.990 landscape →
Q9GRX4 0.990 Q9GRX4 →
Q8TC92 0.986 Q8TC92 →
Q91WT8 0.986 Q91WT8 →
Q9GRW7 0.986 Q9GRW7 →
Q04047 0.986 Q04047 →
Q4R4J1 0.985 Q4R4J1 →
Q5YD48 0.985 Q5YD48 →
Q8CGF7 0.985 Q8CGF7 →
Q8BHR2 0.985 Q8BHR2 →
A9LNK9 0.985 A9LNK9 →
SMARCC2 SWI/SNF complex subunit SMARCC2 0.984 landscape →
RBM22 Pre-mRNA-splicing factor RBM22 0.984 landscape →
Q923K9 0.984 Q923K9 →
Q4V7D7 0.984 Q4V7D7 →
O43439 0.984 O43439 →
Q6DDW4 0.984 Q6DDW4 →
B1H1X4 0.984 B1H1X4 →
Q93VI4 0.984 Q93VI4 →
Q9U1N0 0.984 Q9U1N0 →